This is the authors' abstract. We don't add key points for this paper.
Introduction: Bladder tumors are the 2nd largest urological cancer with an increasing incidence of about 1% per year. The aim of our study was to determine the prevalence of bladder tumors at the University Clinic of Urology-Andrology of the National University Hospital Center Hubert Koutoukou Maga of Cotonou, to describe the diagnostic aspects, and to evaluate the therapeutic modalities used. Patients and Methods: This was a descriptive, retrospective, and analytical study with a cross-sectional data collection, listing 68 cases of bladder tumors over a 10-year period from January 2013 to December 2022. Results: Men predominated (67.65%) with a sex ratio of 2.09. The mean age of patients was 57.22 ± 13.79 years, with extremes of 16 years and 89 years. The age group of 60 to 69 years was the most represented and made up 29.41% of patients. Hematuria was the main reason for consultation (45.59%). History was dominated by smoking (17.65%) and urinary schistosomiasis (14.71%). One of the patients was exposed to occupational carcinogens. The clinical picture was dominated by conjunctival pallor (47.1%) and deterioration in general condition (42.65%). Para clinically, pelvic ultrasound was performed by 88.24% of patients with a sensitivity of 77.84%. Cystoscopy performed by 36 patients (52.94%) confirmed the lesion in 97.22% of cases. The tumors were budding (88.57%), sessile (97.14%) and multifocal (20%). The non-muscle infiltrating bladder tumor accounted for 51.47% of cases. Histopathological examination was performed in 22 patients (32.35%) with a predominance of urothelial carcinoma. Forty patients (58.82%) had received treatment, including 38 surgeries and 2 endovesical instillations. A total of 61.76% of patients were lost to follow-up, 8.82% had progression-free follow-up, 2.94% had tumor regrowth, and 26.47% died. Conclusion: Bladder tumours remain a public health problem. Diagnosis is clinical and, above all, paraclinical. The best treatment is to prevent risk factors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Douro et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: